Home » FDA Advisory Board Approves International Harmonization Strategy
FDA Advisory Board Approves International Harmonization Strategy
October 16, 2006
The U.S. Food and Drug Administration (FDA) Advisory Committee for Pharmaceutical Science overwhelmingly approved the agencys strategy for developing new international harmonization approaches for drug development, but members expressed reservations about the development of new guidance to supplement the international standards.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor